Peptide Synthesis Using BOP-OPPF6 Activation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing peptides with N-alkylamino acids face challenges such as low conversion rates, residual starting materials, and the need for additional deprotection steps, which affect yield and quality.

Innovation Solution

A method involving the mixing of an N-terminal protected amino acid or peptide with a carboxylic acid activating agent and an amino acid or peptide with an N-alkyl group, using specific activating agents and silylating agents to achieve efficient peptide synthesis with an unprotected C-terminal.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional activation methods (pivaloyl chloride, isobutylchloroformate, HATU) are used to produce peptides with N-alkylamino acids, then peptide bonds can be formed, but the conversion rate is insufficient and large amounts of starting material remain

Engineering Contradiction:
Improveconversion rateVSAvoidreaction completeness
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent changes the chemical parameters of the activation method by using benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP-OPPF6) instead of conventional activating agents. This parameter change in the reagent structure and properties enables sufficient conversion of N-alkylamino acids to peptide bonds, resolving the incomplete reaction issue while maintaining high reaction completeness.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If methods with C-terminal protection are used, then peptide synthesis can proceed, but additional deprotection steps are required which reduce efficiency

Engineering Contradiction:
Improvesynthesis simplicityVSAvoidnumber of steps
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent extracts and removes the C-terminal protection step from the synthesis pathway by directly producing peptides with unprotected C-terminals. The use of BOP-OPPF6 activation enables the reaction to proceed without requiring subsequent deprotection operations, thereby reducing the total number of steps while maintaining ease of manufacture through a streamlined process.

Inventive Principle:
Principle #2Taking out (Extraction)

3Productivity

If HATU is used as activating agent, then peptide bonds can be formed, but the explosive triazole structure makes it unsuitable for industrial production

Engineering Contradiction:
Improvereaction efficiencyVSAvoidexplosive hazard
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the hazardous HATU reagent with BOP-OPPF6, which lacks explosive properties. This substitution maintains high reaction efficiency for peptide bond formation while eliminating the safety hazard associated with the triazole structure, making the process suitable for industrial production where safety is paramount.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Adaptability or versatility

If N-alkylamino acids are introduced using conventional methods, then peptide diversity can be achieved, but residual starting materials form peptides lacking amino acids which are difficult to remove

Engineering Contradiction:
Improvepeptide structure varietyVSAvoidproduct purity
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent changes the reaction parameters by using BOP-OPPF6 activation which achieves complete conversion of N-alkylamino acids. This parameter change eliminates residual starting materials that would otherwise contaminate the final product, thereby maintaining peptide structure variety while significantly improving product purity and reducing the difficulty of removal.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the production of peptides with N-alkylamino acids in higher yields and with improved quality, eliminating the need for additional deprotection steps and using industrially applicable reagents.

Implementation Method 1

the C-terminal of an N-terminal protected amino acid is activated with pivaloyl chloride

Methodology Applied
Scientific EffectCarboxylic acid activation: Chemical Bonding

Implementation Method 2

a benzyl ester of an N-methylamino acid is reacted therewith

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 3

silylated N-methylglycine (sarcosine) or proline

Methodology Applied
Scientific EffectSilylation: Chemical Bonding

Implementation Method 4

a peptide in which the C-terminal of the product is protected... a method in which the C-terminal of an N-terminal protected amino acid is activated with pivaloyl chloride, and a benzyl ester of an N-methylamino acid is reacted therewith

Methodology Applied
Scientific EffectCondensation reaction: Chemical Bonding

Data Source

PatentUS12240871B2Method for producing peptide compound
Publication Date: 2025.03.04 NISSAN CHEM CORP
  • US12240871B2 patent drawing
  • US12240871B2 patent drawing
  • US12240871B2 patent drawing

AI summary

The present invention is to provide a method for producing a peptide containing an N-alkylamino acid, which comprises the following Steps (1) to (3). Step (1): a step of mixing an N-terminal protected amino acid or an N-terminal protected peptide with a carboxylic acid halide or a halogenated alkyl formate; Step (2): a step of mixing an amino acid or a peptide in which the N-terminal and the C-terminal are not protected with a trialkylsilylating agent; and Step (3): a step of mixing the product obtained in Step (1) with the product obtained in Step (2).